Utility of gingival crevicular fluid components for periodontal diagnosis.
biomarkers
diagnosis
gingival crevicular fluid
periodontitis
Journal
Periodontology 2000
ISSN: 1600-0757
Titre abrégé: Periodontol 2000
Pays: Denmark
ID NLM: 9313276
Informations de publication
Date de publication:
14 Jul 2024
14 Jul 2024
Historique:
revised:
18
06
2024
received:
09
02
2024
accepted:
28
06
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
aheadofprint
Résumé
Periodontal diseases are highly prevalent chronic diseases, and severe periodontitis creates functional and esthetic problems and decreases self-esteem for a large percentage of the older population worldwide. In many cases of periodontitis, there is no distinct tell-tale pain that motivates a patient to seek treatment, rather the signs become clinically detectable late, and typically when the disease has progressed to a problematic level for the life of the dentition. Early periodontal screening and diagnostics tools will provide early recognition of periodontal diseases and facilitate timely management of the disease to reduce tooth loss. To this goal, gingival crevicular fluid is easily sampled, can be repeatedly and non-invasively collected, and can be tested for potential biomarkers. Moreover, the site specificity of periodontal diseases enhances the usefulness of gingival crevicular fluid sampled from specific sites as a biofluid for diagnosis and longitudinal monitoring of periodontal diseases. The present review aimed to provide up-to-date information on potential diagnostic biomarkers with utility that can be assayed from gingival crevicular fluid samples, focusing on what is new and useful and providing only general historic background textually and in a tabulated format.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Periodontology 2000 published by John Wiley & Sons Ltd.
Références
Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990–2010: a systematic review and meta‐regression. J Dent Res. 2014;93(11):1045‐1053.
Bartold PM, Van Dyke TE. Periodontitis: a host‐mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000. 2013;62(1):203‐217.
Kinane DF, Bartold PM. Clinical relevance of the host responses of periodontitis. Periodontol 2000. 2007;43:278‐293.
Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000. 2017;75(1):317‐329.
Bartold PM, Van Dyke TE. An appraisal of the role specific bacteria in the initial pathogenesis of periodontitis. J Clin Periodontol. 2019;46(1):6‐11.
Deng K, Zonta F, Yang H, Pelekos G, Tonetti MS. Development of a machine learning multiclass screening tool for periodontal health status based on non‐clinical parameters and salivary biomarkers. J Clin Periodontol. 2023. doi:10.1111/jcpe.13856
Heitz‐Mayfield LJA. Conventional diagnostic criteria for periodontal diseases (plaque‐induced gingivitis and periodontitis). Periodontol 2000. 2024. doi:10.1111/prd.12579
Silberring J, Ciborowski P. Biomarker discovery and clinical proteomics. Trends Anal Chem. 2010;29(2):128‐140.
Buduneli N, Kinane DF. Host‐derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol. 2011;38(Suppl 11):85‐105.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition [published correction appears in J Periodontol. 2018;89(12):1475]. J Periodontol. 2018;89(Suppl 1):S159‐S172.
Bhuyan R, Bhuyan SK, Mohanty JN, Das S, Juliana N, Juliana IF. Periodontitis and its inflammatory changes linked to various systemic diseases: a review of its underlying mechanisms. Biomedicine. 2022;10(10):2659.
van der Velden U. Purpose and problems of periodontal disease classification. Periodontol 2000. 2005;39:13‐21.
Xiang X, Sowa MG, Iacopino AM, et al. An update on novel non‐invasive approaches for periodontal diagnosis. J Periodontol. 2010;81:186‐198.
Buduneli N. Biological samples for biomarkers: strengths and weaknesses. Biomarkers in Periodontal Health and Disease: Rationale, Benefits, and Future Directions. Vol 62. Springer Nature; 2020:59‐68.
Fakheran O, Bencze B, Mischak I, Vegh D, Payer M. The reliability of using gingival crevicular blood to measure blood glucose and hba1c levels in the dental setting: a systematic review and meta‐analysis. Clin Oral Investig. 2024;28(5):299. doi:10.1007/s00784-024-05685-4
Chen X, Wolff L, Aeppli D, et al. Cigarette smoking, salivary/gingival crevicular fluid cotinine and periodontal status. A 10‐year longitudinal study. J Clin Periodontol. 2001;28(4):331‐339.
Loos BG, Tjoa S. Host‐derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000. 2005;39:53‐72.
Miller CS, Foley JD, Bailey AL, et al. Current developments in salivary diagnostics. Biomark Med. 2010;4(1):171‐189.
Ghallab NA. Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: review of the current evidence. Arch Oral Biol. 2018;87:115‐124.
Almehmadi AH, Alghamdi F. Biomarkers of alveolar bone resorption in gingival crevicular fluid: a systematic review. Arch Oral Biol. 2018;93:12‐21.
Baima G, Corana M, Iaderosa G, et al. Metabolomics of gingival crevicular fluid to identify biomarkers for periodontitis: a systematic review with meta‐analysis. J Periodontal Res. 2021;56(4):633‐645.
Arias‐Bujanda N, Regueira‐Iglesias A, Balsa‐Castro C, Nibali L, Donos N, Tomás I. Accuracy of single molecular biomarkers in gingival crevicular fluid for the diagnosis of periodontitis: a systematic review and meta‐analysis. J Clin Periodontol. 2019;46:1166‐1182.
Blanco‐Pintos T, Regueira‐Iglesias A, Seijo‐Porto I, et al. Accuracy of periodontitis diagnosis obtained using multiple molecular biomarkers in oral fluids: a systematic review and meta‐analysis. J Clin Periodontol. 2023;50(11):1420‐1443.
Alamri MM, Antonoglou GN, Proctor G, Balsa‐Castro C, Tomas I, Nibali L. Biomarkers for diagnosis of stage III, grade C with molar incisor pattern periodontitis in children and young adults: a systematic review and meta‐analysis. Clin Oral Investig. 2023;27(9):4929‐4955.
Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014;64(1):57‐80.
Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD. Periodontal disease at the biofilm‐gingival interface. J Periodontol. 2007;78(10):1911‐1925.
Kinney JS, Morelli T, Oh M, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol. 2014;41(2):113‐120.
Stadler AF, Angst PD, Arce RM, Gomes SC, Oppermann RV, Susin C. Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta‐analysis. J Clin Periodontol. 2016;43(9):727‐745.
Tomás I, Arias‐Bujanda N, Alonso‐Sampedro M, et al. Cytokine‐based predictive models to estimate the probability of chronic periodontitis: development of diagnostic nomograms. Sci Rep. 2017;7(1):11580.
Shaddox LM, Wiedey J, Calderon NL, et al. Local inflammatory markers and systemic endotoxin in aggressive periodontitis. J Dent Res. 2011;90(9):1140‐1144.
Emingil G, Atilla G, Hüseyinov A. Gingival crevicular fluid monocyte chemoattractant protein‐1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol. 2004;31(10):829‐834.
Kurtiş B, Tüter G, Serdar M, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein‐1 and tumor necrosis factor‐alpha in patients with chronic and aggressive periodontitis. J Periodontol. 2005;76(11):1849‐1855.
Gupta M, Chaturvedi R, Jain A. Role of monocyte chemoattractant protein‐1 (MCP‐1) as an immune‐diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine. 2013;61(3):892‐897.
Pradeep AR, Daisy H, Hadge P. Gingival crevicular fluid levels of monocyte chemoattractant protein‐1 in periodontal health and disease. Arch Oral Biol. 2009;54(5):503‐509.
Kim MS, Day CJ, Morrison NA. MCP‐1 is induced by receptor activator of nuclear factor‐{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony‐stimulating factor suppression of osteoclast formation. J Biol Chem. 2005;280(16):16163‐16169.
Chung RM, Grbíc JT, Lamster IB. Interleukin‐8 and beta‐glucuronidase in gingival crevicular fluid. J Clin Periodontol. 1997;24(3):146‐152.
Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9(3):248‐266.
Yucel‐Lindberg T, Båge T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med. 2013;15:e7.
Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane‐bound chemokine with a CX3C motif. Nature. 1997;385(6617):640‐644.
White GE, Greaves DR. Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol. 2012;32(3):589‐594.
Jones BA, Beamer M, Ahmed S. Fractalkine/CX3CL1: a potential new target for inflammatory diseases. Mol Interv. 2010;10(5):263‐270.
Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91(4):521‐530.
Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation. 2003;108(20):2498‐2504.
White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR. Fractalkine has anti‐apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res. 2010;85(4):825‐835.
Ikejima H, Imanishi T, Tsujioka H, et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circ J. 2010;74(2):337‐345.
Shah R, Hinkle CC, Ferguson JF, et al. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes. 2011;60(5):1512‐1518.
Koch AE. Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum. 2005;52(3):710‐721.
Balci N, Cekici A, Kurgan Ş, Sahinkaya S, Serdar MA. Potential biomarkers reflecting inflammation in patients with severe periodontitis: fractalkine (CX3CL1) and its receptor (CX3CR1). J Periodontal Res. 2021;56(3):589‐596.
Kajikawa T, Mastellos DC, Hasturk H, et al. C3‐targeted host‐modulation approaches to oral inflammatory conditions. Semin Immunol. 2022;59:101608.
Huang RY, Tseng FY, You JJ, et al. Targeting therapeutic agent against C3b/C4b, SB002, on the inflammation‐induced bone loss in experimental periodontitis. J Clin Periodontol. 2023;50(5):657‐670.
Huang RY, Tseng FY, Cheng CD, et al. Complement components C3b and C4b as potential reliable site‐specific diagnostic biomarkers for periodontitis. J Periodontal Res. 2023;58(5):1020‐1030.
Atanasova T, Stankova T, Bivolarska A, Vlaykova T. Matrix metalloproteinases in Oral health‐special attention on MMP‐8. Biomedicine. 2023;11(6):1514.
Gul SS, Abdulkareem AA, Sha AM, Rawlinson A. Diagnostic accuracy of Oral fluids biomarker profile to determine the current and future status of periodontal and peri‐implant diseases. Diagnostics (Basel). 2020;10(10):838.
Kinane DF, Preshaw PM, Loos BG, Working Group 2 of Seventh European Workshop on Periodontology. Host‐response: understanding the cellular and molecular mechanisms of host‐microbial interactions—consensus of the seventh European workshop on periodontology. J Clin Periodontol. 2011;38(Suppl 11):44‐48.
Leppilahti JM, Hernández‐Ríos PA, Gamonal JA, et al. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site‐specific diagnostic value for chronic periodontitis. J Clin Periodontol. 2014;41(4):348‐356.
Baeza M, Garrido M, Hernández‐Ríos P, et al. Diagnostic accuracy for apical and chronic periodontitis biomarkers in gingival crevicular fluid: an exploratory study. J Clin Periodontol. 2016;43(1):34‐45.
de Brouwer P, Bikker FJ, Brand HS, Kaman WE. Is TIMP‐1 a biomarker for periodontal disease? A systematic review and meta‐analysis. J Periodontal Res. 2022;57(2):235‐245.
Tervahartiala T, Pirilä E, Ceponis A, et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP‐2, ‐8, ‐13, and ‐14) and matrilysin (MMP‐7) in adult and localized juvenile periodontitis. J Dent Res. 2000;79(12):1969‐1977.
Sorsa T, Gursoy UK, Nwhator S, et al. Analysis of matrix metalloproteinases, especially MMP‐8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000. 2016;70(1):142‐163.
Luchian I, Goriuc A, Sandu D, Covasa M. The role of matrix metalloproteinases (MMP‐8, MMP‐9, MMP‐13) in periodontal and peri‐implant pathological processes. Int J Mol Sci. 2022;23(3):1806.
Lähteenmäki H, Tervahartiala T, Räisänen IT, et al. Active MMP‐8 point‐of‐care (PoC)/chairside enzyme‐test as an adjunctive tool for early and real‐time diagnosis of peri‐implantitis. Clin Exp Dent Res. 2022;8(2):485‐496.
Lee W, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res. 1995;30(1):23‐33.
Sorsa T, Alassiri S, Grigoriadis A, et al. Active MMP‐8 (aMMP‐8) as a grading and staging biomarker in the periodontitis classification. Diagnostics (Basel). 2020;10(2):61.
Gupta S, Sahni V, Raisanen IT, et al. Linking oral microbial proteolysis to aMMP‐8 PoC diagnostics along with the stage and grade of periodontitis: a cross‐sectional study. Oral Dis. 2023;29(1):285‐289.
Deng K, Pelekos G, Jin L, Tonetti MS. Diagnostic accuracy of a point‐of‐care aMMP‐8 test in the discrimination of periodontal health and disease. J Clin Periodontol. 2021;48(8):1051‐1065.
Deng K, Wei S, Xu M, Shi J, Lai H, Tonetti MS. Diagnostic accuracy of active matrix metalloproteinase‐8 point‐of‐care test for the discrimination of periodontal health status: comparison of saliva and oral rinse samples. J Periodontal Res. 2022;57(4):768‐779.
Sorsa T, Grigoriadis A, Sakellari D, et al. On the accuracy, sensitivity, and grading of mouthrinse active matrix metalloproteinase‐8 (aMMP‐8) point‐of‐care testing (POCT). J Clin Periodontol. 2021;48(11):1495‐1498.
Sorsa T, Nwhator SO, Sakellari D, et al. aMMP‐8 Oral fluid PoC test in relation to oral and systemic diseases. Front Oral Health. 2022;3:897115.
Öztürk VÖ, Emingil G, Umeizudike K, et al. Evaluation of active‐matrix metalloproteinase‐8 (aMMP‐8) chair‐side test as a diagnostic biomarker in the staging of periodontal diseases. Arch Oral Biol. 2021;124:104955.
Sapna G, Gokul S, Bagri‐Manjrekar K. Matrix metalloproteinases and periodontal diseases. Oral Dis. 2014;20:538‐550.
Yakob M, Meurman JH, Sorsa T, Söder B. Treponema denticola associates with increased levels of MMP‐8 and MMP‐9 in gingival crevicular fluid. Oral Dis. 2013;19:694‐701.
Chen M, Cai W, Zhao S, et al. Oxidative stress‐related biomarkers in saliva and gingival crevicular fluid associated with chronic periodontitis: a systematic review and meta‐analysis. J Clin Periodontol. 2019;46(6):608‐622.
Wei D, Zhang XL, Wang YZ, Yang CX, Chen G. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J. 2010;55(1):70‐78.
Akalin FA, Toklu E, Renda N. Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Periodontol. 2005;32(3):238‐243.
Canakci V, Yildirim A, Canakci CF, Eltas A, Cicek Y, Canakci H. Total antioxidant capacity and antioxidant enzymes in serum, saliva, and gingival crevicular fluid of preeclamptic women with and without periodontal disease. J Periodontol. 2007;78(8):1602‐1611.
Srinath R, Acharya AB, Thakur SL. Salivary and gingival crevicular fluid melatonin in periodontal health and disease. J Periodontol. 2010;81(2):277‐283.
Almughrabi OM, Marzouk KM, Hasanato RM, Shafik SS. Melatonin levels in periodontal health and disease. J Periodontal Res. 2013;48(3):315‐321.
Ghallab NA, Hamdy E, Shaker OG. Malondialdehyde, superoxide dismutase and melatonin levels in gingival crevicular fluid of aggressive and chronic periodontitis patients. Aust Dent J. 2016;61(1):53‐61.
Cutando A, Gómez‐Moreno G, Arana C, Acuña‐Castroviejo D, Reiter RJ. Melatonin: potential functions in the oral cavity. J Periodontol. 2007;78(6):1094‐1102.
Koyama H, Nakade O, Takada Y, Kaku T, Lau KH. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down‐regulation of the RANKL‐mediated osteoclast formation and activation. J Bone Miner Res. 2002;17(7):1219‐1229.
Mrnka L, Hock M, Rybová M, Pácha J. Melatonin inhibits prostaglandin E2‐ and sodium nitroprusside‐induced ion secretion in rat distal colon. Eur J Pharmacol. 2008;581(1–2):164‐170.
Reiter RJ, Rosales‐Corral SA, Liu XY, Acuna‐Castroviejo D, Escames G, Tan DX. Melatonin in the oral cavity: physiological and pathological implications. J Periodontal Res. 2015;50(1):9‐17.
Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem. 1999;274(31):22041‐22047.
Hassan SH, El‐Refai MI, Ghallab NA, Kasem RF, Shaker OG. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. Dis Markers. 2015;2015:341259.
Belibasakis GN, Bostanci N. The RANKL‐OPG system in clinical periodontology. J Clin Periodontol. 2012;39(3):239‐248.
Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000. 2010;52(1):163‐206.
Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309‐319.
Théoleyre S, Kwan Tat S, Vusio P, et al. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Biochem Biophys Res Commun. 2006;347(2):460‐467.
Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008;29(2):155‐192.
Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T. Role of periodontal pathogenic bacteria in RANKL‐mediated bone destruction in periodontal disease. J Oral Microbiol. 2010;2:5532. doi:10.3402/jom.v2i0.5532
Wise GE, Lumpkin SJ, Huang H, Zhang Q. Osteoprotegerin and osteoclast differentiation factor in tooth eruption. J Dent Res. 2000;79(12):1937‐1942.
Garlet TP, Coelho U, Repeke CE, Silva JS, Cunha FQ, Garlet GP. Differential expression of osteoblast and osteoclast chemmoatractants in compression and tension sides during orthodontic movement. Cytokine. 2008;42(3):330‐335.
Kobayashi‐Sakamoto M, Hirose K, Isogai E, Chiba I. NF‐kappaB‐dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells. Biochem Biophys Res Commun. 2004;315(1):107‐112.
Nakashima T, Kobayashi Y, Yamasaki S, et al. Protein expression and functional difference of membrane‐bound and soluble receptor activator of NF‐kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000;275(3):768‐775.
Liu D, Xu JK, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med. 2003;11(1):17‐21.
Özçaka Ö, Nalbantsoy A, Köse T, Buduneli N. Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. Aust Dent J. 2010;55(4):405‐410.
Bostanci N, Ilgenli T, Emingil G, et al. Differential expression of receptor activator of nuclear factor‐kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res. 2007;42(4):287‐293.
Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res. 2004;83(2):166‐169.
Sarlati F, Sattari M, Razzaghi S, Nasiri M. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid. Dent Res J (Isfahan). 2012;9(6):752‐757.
Segarra‐Vidal M, Guerra‐Ojeda S, Vallés LS, et al. Effects of photodynamic therapy in periodontal treatment: a randomized, controlled clinical trial. J Clin Periodontol. 2017;44(9):915‐925.
Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29(4):403‐440.
Bostanci N, Saygan B, Emingil G, Atilla G, Belibasakis GN. Effect of periodontal treatment on receptor activator of NF‐κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. J Clin Periodontol. 2011;38(5):428‐433.
Buduneli N, Buduneli E, Kütükçüler N. Interleukin‐17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non‐smoking patients with chronic periodontitis during initial periodontal treatment. J Periodontol. 2009;80(8):1274‐1280.
Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000. 2016;70(1):53‐64.
Giannobile WV. C‐telopeptide pyridinoline cross‐links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci. 1999;878:404‐412.
Giannobile WV, Al‐Shammari KF, Sarment DP. Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol 2000. 2003;31:125‐134.
Gallop PM, Lian JB, Hauschka PV. Carboxylated calcium‐binding proteins and vitamin K. N Engl J Med. 1980;302(26):1460‐1466.
Kunimatsu K, Mataki S, Tanaka H, et al. A cross‐sectional study on osteocalcin levels in gingival crevicular fluid from periodontal patients. J Periodontol. 1993;64(9):865‐869.
Becerik S, Afacan B, Oztürk VÖ, Atmaca H, Emingil G. Gingival crevicular fluid calprotectin, osteocalcin and cross‐linked N‐terminal telopeptid levels in health and different periodontal diseases. Dis Markers. 2011;31(6):343‐352.
Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone‐type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46(8):310‐319.
Bullon P, Chandler L, Segura Egea JJ, Perez Cano R, Martinez SA. Osteocalcin in serum, saliva and gingival crevicular fluid: their relation with periodontal treatment outcome in postmenopausal women. Med Oral Patol Oral Cir Bucal. 2007;12(3):E193‐E197.
Lee AJ, Walsh TF, Hodges SJ, Rawlinson A. Gingival crevicular fluid osteocalcin in adult periodontitis. J Clin Periodontol. 1999;26(4):252‐256.
Nakashima K, Giannopoulou C, Andersen E, et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol. 1996;23(9):832‐838.
Afacan B, Çınarcık S, Gürkan A, et al. Full‐mouth disinfection effects on gingival fluid calprotectin, osteocalcin, and N‐telopeptide of type I collagen in severe periodontitis. J Periodontol. 2020;91(5):638‐650.
Bostanci N, Belibasakis GN. Gingival crevicular fluid and its immune mediators in the proteomic era. Periodontol 2000. 2018;76(1):68‐84.
Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000. 2003;31:32‐42.
Bostanci N, Bao K, Greenwood D, Silbereisen A, Belibasakis GN. Periodontal disease: from the lenses of light microscopy to the specs of proteomics and next‐generation sequencing. Adv Clin Chem. 2019;93:263‐290.
Bao K, Belibasakis GN, Selevsek N, Grossmann J, Bostanci N. Proteomic profiling of host‐biofilm interactions in an oral infection model resembling the periodontal pocket. Sci Rep. 2015;5:15999.
Khurshid Z, Mali M, Naseem M, Najeeb S, Zafar MS. Human gingival crevicular fluids (GCF) proteomics: an overview. Dent J (Basel). 2017;5(1):12.
Choi YJ, Heo SH, Lee JM, Cho JY. Identification of azurocidin as a potential periodontitis biomarker by a proteomic analysis of gingival crevicular fluid. Proteome Sci. 2011;9:42.
Nalmpantis D, Gatou A, Fragkioudakis I, Margariti A, Skoura L, Sakellari D. Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis. J Periodontal Res. 2020;55(2):209‐214.
Baliban RC, Sakellari D, Li Z, DiMaggio PA, Garcia BA, Floudas CA. Novel protein identification methods for biomarker discovery via a proteomic analysis of periodontally healthy and diseased gingival crevicular fluid samples. J Clin Periodontol. 2012;39:203‐212.
Ngo LH, Veith PD, Chen YY, Chen D, Darby IB, Reynolds EC. Mass spectrometric analyses of peptides and proteins in human gingival crevicular fluid. J Proteome Res. 2010;9(4):1683‐1693.
Bostanci N, Heywood W, Mills K, Parkar M, Nibali L, Donos N. Application of label‐free absolute quantitative proteomics in human gingival crevicular fluid by LC/MS E (gingival exudatome). J Proteome Res. 2010;9(5):2191‐2199.
Öztürk VÖ, Emingil G, Osterwalder V, Bostanci N. The Actin‐bundling protein L‐plastin: a novel local inflammatory marker associated with periodontitis. J Periodontal Res. 2015;50(3):337‐346.
Silva‐Boghossian CM, Colombo AP, Tanaka M, Rayo C, Xiao Y, Siqueira WL. Quantitative proteomic analysis of gingival crevicular fluid in different periodontal conditions. PLoS ONE. 2013;8(10):e75898.
Torres A, Michea MA, Végvári Á, et al. Proteomic profile of human gingival crevicular fluid reveals specific biological and molecular processes during clinical progression of periodontitis. J Periodontal Res. 2023;58(5):1061‐1081.
Baliban RC, Sakellari D, Li Z, Guzman YA, Garcia BA, Floudas CA. Discovery of biomarker combinations that predict periodontal health or disease with high accuracy from GCF samples based on high‐throughput proteomic analysis and mixed‐integer linear optimization. J Clin Periodontol. 2013;40(2):131‐139.
Kaman WE, Galassi F, de Soet JJ, et al. Highly specific protease‐based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis. J Clin Microbiol. 2012;50(1):104‐112.